Drug
Islatravir
Islatravir: highest development phase Phase 2, developed by Merck. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Islatravir NCT05115838 | Phase 2 | Human Immunodeficiency Virus |
| Islatravir (ISL) NCT06811246 | Phase 1 | Healthy |
Latest
No recent events.
Follow Islatravir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.